BioCentury
ARTICLE | Financial News

BioSante financial update

February 13, 2012 8:00 AM UTC

BioSante exchanged $5 million of its 3.125% convertible senior notes due May 1, 2013, for 6.7 million shares. The company has $15.8 million outstanding in the notes. ...